EUVIMEDOpdag EUVIMED
Systematische ÜbersichtLeitlinieOpen access · CC BY 4.0

Antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID)

Anette Loeffler iD, Christine L Cain iD, Lluís Ferrer iD, Koji Nishifuji, Katarina Varjonen, Mark G Papich, Luca Guardabassi, Siân M Frosini iD, Emi N Barker, J Scott Weese

Veterinary Dermatology · 2025-06 · 36 (3) · 234-282

DOI: 10.1111/vde.13342 ↗

At a glance

Systematische Übersicht in Veterinary Dermatology, published online on 2025-05-07. Written by Anette Loeffler and 9 co-authors. Institution: Department of Clinical Science and Services, Royal Veterinary College, Hatfield, UK. Major MEDLINE topics: Dog Diseases, Pyoderma, Anti-Bacterial Agents, Staphylococcal Skin Infections. Cited 62 times so far (Crossref); 236 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Canine pyoderma is one of the most common presentations in small animal practice, frequently leading to antimicrobial prescribing.

Objectives

To provide clinicians with antimicrobial treatment guidelines for staphylococcal pyoderma, including those involving meticillin‐resistant staphylococci. Guidance on diagnosing surface, superficial and deep pyoderma and their underlying primary causes, is included. Recommendations aim to optimise treatment outcomes while promoting responsible antimicrobial use. Materials and Methods Evidence was gathered from a systematic literature review of English‐language treatment studies for canine pyoderma up to 23 December 2023. Quality was assessed using SORT criteria and combined with authors' consensus evaluation. Recommendations were voted on in an iterative process, followed by a Delphi‐style feedback process before final agreement by the authors.

Results

Cytology should be performed in all cases before antimicrobials are used. Topical antimicrobial therapy alone is the treatment‐of‐choice for surface and superficial pyodermas. Systemic antimicrobials should be reserved for deep pyoderma and for superficial pyoderma when topical therapy is not effective. Systemic therapy, with adjunctive topical treatment, is initially provided for 2 weeks in superficial and 3 weeks in deep pyoderma, followed by re‐examination to assess progress and manage primary causes. First‐choice drugs have expected efficacy against the majority of meticillin‐susceptible Staphylococcus pseudintermedius; for all other drugs, laboratory testing should confirm susceptibility and exclude suitability of safer alternatives. As culture and susceptibility testing are essential for rationalising systemic therapy, laboratories and practices should price them reasonably to encourage use. Proactive topical therapy using antiseptics may help prevent recurrences. Conclusions and Clinical Relevance The accessibility of the skin offers excellent, achievable opportunities for antimicrobial stewardship.

Subjects

MeSH terms (MEDLINE)

Dog DiseasesPyodermaAnti-Bacterial AgentsStaphylococcal Skin InfectionsAnimalsDogs

Substances

Anti-Bacterial Agents

Authors and institutions

  • Department of Clinical Science and Services, Royal Veterinary College, Hatfield, UK.
  • Department of Clinical Sciences and Advanced Medicine, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Animal Medicine and Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Division of Animal Life Science, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
  • Anicura Albano Animal Hospital, Danderyd, Sweden.
  • College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.

ORCID profiles: Anette Loeffler, Christine L Cain, Lluís Ferrer, Siân M Frosini

Cite

APA

Loeffler, A., Cain, C. L., Ferrer, L., Nishifuji, K., Varjonen, K., Papich, M. G., Guardabassi, L., Frosini, S. M., Barker, E. N., & Weese, J. S. (2025). Antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID). Veterinary Dermatology, 36(3), 234-282. https://doi.org/10.1111/vde.13342

Vancouver

Loeffler A, Cain CL, Ferrer L, Nishifuji K, Varjonen K, Papich MG, et al. Antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID). Veterinary Dermatology. 2025;36(3):234-282. doi:10.1111/vde.13342

BibTeX
@article{Loeffler2025,
  author = {Loeffler, Anette and Cain, Christine L and Ferrer, Lluís and Nishifuji, Koji and Varjonen, Katarina and Papich, Mark G and Guardabassi, Luca and Frosini, Siân M and Barker, Emi N and Weese, J Scott},
  title = {Antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID)},
  journal = {Veterinary Dermatology},
  year = {2025},
  volume = {36},
  number = {3},
  pages = {234--282},
  doi = {10.1111/vde.13342}
}
Start for free →